{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Jacksonville&page=56&state=Florida", "query": { "state": "Florida", "city": "Jacksonville", "page": 56 }, "page_size": 10 }, "pagination": { "page": 56, "page_size": 10, "total_count": 7632, "total_pages": 764, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Jacksonville&page=57&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Jacksonville&page=55&state=Florida&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T22:50:39.328Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00003389", "title": "Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Bleomycin", "type": "DRUG" }, { "name": "Vinblastine", "type": "DRUG" }, { "name": "Dacarbazine", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Mechlorethamine", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Radiotherapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Eastern Cooperative Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 854, "start_date": "1999-06-17", "completion_date": "2016-05", "has_results": true, "last_update_posted_date": "2023-06-29", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 517, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 329 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003389" }, { "nct_id": "NCT00066690", "title": "Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Estrogen Receptor Positive Breast Cancer", "Progesterone Receptor Positive Tumor", "Recurrent Breast Carcinoma", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage IIA Breast Cancer", "Stage IIB Breast Cancer", "Stage IIIA Breast Cancer" ], "interventions": [ { "name": "Exemestane", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Oophorectomy", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Tamoxifen", "type": "DRUG" }, { "name": "Triptorelin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE", "RADIATION" ], "sponsor": "ETOP IBCSG Partners Foundation", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 3066, "start_date": "2003-12-17", "completion_date": "2024-11-06", "has_results": true, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 480, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Scottsdale, Arizona + 323 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Berkeley", "state": "California" }, { "city": "Burlingame", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00066690" }, { "nct_id": "NCT00655382", "title": "Dynamic MRI Evaluation Post Operative Stapled Trans Anal Rectal Resection (STARR) Procedure", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obstructive Defecation Syndrome", "Outlet Obstruction" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "FEMALE", "summary": "18 Years to 90 Years · Female only" }, "enrollment_count": 10, "start_date": "2007-10", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2010-05-21", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00655382" }, { "nct_id": "NCT00624468", "title": "Atacicept in Subjects With Optic Neuritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Optic Neuritis" ], "interventions": [ { "name": "Atacicept", "type": "DRUG" }, { "name": "Placebo matched to atacicept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 34, "start_date": "2008-06", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2016-02-17", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Aurora, Colorado • Fairfield, Connecticut + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Fairfield", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "East Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624468" }, { "nct_id": "NCT02167997", "title": "EffectiveNess and SAfety of Small ANeurysm COiling Trial", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aneurysm" ], "interventions": [], "intervention_types": [], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 252, "start_date": "2013-11", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2016-08-18", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 17, "location_summary": "Santa Barbara, California • Englewood, Colorado • Gainesville, Florida + 14 more", "locations": [ { "city": "Santa Barbara", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02167997" }, { "nct_id": "NCT05820997", "title": "Paravertebral Block vs no Block in Open Pancreaticoduodenectomy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pancreaticoduodenectomy" ], "interventions": [ { "name": "Ropivacaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2023-04-24", "completion_date": "2024-12-04", "has_results": true, "last_update_posted_date": "2025-12-16", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05820997" }, { "nct_id": "NCT01455597", "title": "Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vulvovaginal Atrophy" ], "interventions": [ { "name": "WC3011 Estradiol Vaginal Cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Warner Chilcott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "FEMALE", "summary": "35 Years and older · Female only" }, "enrollment_count": 309, "start_date": "2011-10-20", "completion_date": "2012-12-03", "has_results": true, "last_update_posted_date": "2022-05-09", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 64, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Phoenix, Arizona + 51 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01455597" }, { "nct_id": "NCT03415282", "title": "Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "RVT-501 0.5% topical ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dermavant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 24, "start_date": "2018-02-05", "completion_date": "2018-08-07", "has_results": false, "last_update_posted_date": "2018-05-11", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 12, "location_summary": "Anniston, Alabama • Irvine, California • Jacksonville, Florida + 7 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Irvine", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03415282" }, { "nct_id": "NCT00676338", "title": "Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "exenatide once weekly", "type": "DRUG" }, { "name": "metformin", "type": "DRUG" }, { "name": "sitagliptin", "type": "DRUG" }, { "name": "pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 820, "start_date": "2008-11", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2015-04-09", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 18, "location_summary": "Buena Park, California • Los Angeles, California • Valencia, California + 15 more", "locations": [ { "city": "Buena Park", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Valencia", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00676338" }, { "nct_id": "NCT01652170", "title": "The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acute Appendicitis" ], "interventions": [], "intervention_types": [], "sponsor": "Venaxis, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "2 Years to 20 Years" }, "enrollment_count": 2201, "start_date": "2013-01", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2014-03-24", "last_synced_at": "2026-11-09T22:50:39.328Z", "location_count": 29, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Sacramento, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Sacramento", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01652170" } ] }